La buprénorphine dans le traitement de la dépendance aux opioïdes – Lignes directrices (juin 2009) [Buprenorphine in the treatment of opioid addiction – Guidelines (June 2009); available in French only]

The Collège des médecins du Québec (CMQ) and the Ordre des pharmaciens du Québec (OPQ)

These guidelines cover the pharmacology of buprenorphine; substitution treatment with buprenorphine or long-term therapy (eligibility criteria, medical and psychosocial assessment, treatment agreement and treatment plan); principles for the use of buprenorphine/naloxone for short- or long-term substitution treatment; urine testing; pharmaceutical services; choice of medication for the treatment of opioid addiction; changing substitution medication; chronic pain and opioid addiction; and other aspects of buprenorphine treatment.